StopDown
Funding · 10 September 2026Graph AI$13.3MAutomates drug safety monitoring

Graph AI raises $13.3M for US and Europe expansion

By · Editor ·

Series AFounded 2024
  • Graph AI builds software to automate pharmacovigilance and patient safety operations for pharma companies
  • The company raised $13.3 million led by Insight Partners to expand in the US and Europe
  • This funding accelerates product development and aligns with new global AI regulations for healthcare

What happened

  • Graph AI has secured $13.3 million in Series A funding.
  • Insight Partners led the investment round for the Indian startup.
  • Bessemer Venture Partners, an existing investor, also participated in this round.
  • The CEO is Raghav Parvataraju, who leads the company's strategic direction.
  • The team includes veterans from Google, Wipro, Infosys, LTI, and ServiceNow.
  • Company plans to use funds to expand operations in the US and Europe.
  • Graph AI will accelerate its product development cycle using the new capital.
  • The company aims to serve pharma and biotech clients in North America and other markets.

Why it matters

  • The raise follows a $3 million seed round led by Bessemer in October 2025.
  • Regulatory frameworks like the FDA AI framework and EU AI Act drive demand.
  • The CIOMS Working Group XIV report highlights the need for standardized AI tools.
  • Pharma companies face increasing pressure to ensure patient safety through rigorous monitoring.
  • Automation reduces manual errors in handling adverse event reports significantly.

The business

  • Graph AI offers a Graph Safety platform for automated drug safety monitoring.
  • It automates pharmacovigilance and patient safety operations for pharmaceutical firms.
  • The tech uses AI combined with deterministic controls and validation layers.
  • End-to-end audit trails ensure compliance and transparency in safety reporting.
  • The Intake module captures and triages adverse events from various sources.
  • The Nucleus module serves as a safety database for case processing.
  • The Report module launches in September 2026 for aggregate safety reporting.
  • A Signal module is in development to identify emerging safety patterns.
  • Case processing time drops from over 3 hours to under 10 minutes.
  • Operating costs for clients can be reduced by up to 66%.

The founders

Raghav Parvataraju

CEO
  • He leads Graph AI as the Chief Executive Officer.
  • The team includes veterans from major tech firms like Google and Wipro.
  • Specific educational background or prior roles are not detailed in the facts.

Who put in money

In numbers

$13.3MSeries A amount
$3MSeed round amount · 2025
<10 minutesCase processing time reduction
up to 66%Operating cost reduction

What happens next

  • Expand operations in the US and Europe markets.
  • Accelerate product development across all platform modules.
  • Launch the Report module in September 2026.
  • Develop the Signal module to identify emerging safety patterns.

Earlier rounds

  • Oct 2025 · seed · $3M · led by Bessemer Venture Partners

Words to know

Pharmacovigilance
The practice of monitoring the effects of medical drugs after they are released to the public.
Adverse events
Any unfavorable or unintended sign, abnormal medical situation, or disease that occurs during treatment.
Deterministic controls
Rules-based systems that produce the same output for a given input, ensuring predictable results.
Audit trails
A chronological record that provides documentary evidence of the sequence of activities that have affected a specific operation.

The numbers around it

Healthcare & Life Sciences in September 2026: 11 rounds with a disclosed amount, $114 million in all; the biggest was Ultrahuman ($70 mn). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

All startup news on 10 September 2026 →

Is this Graph AI? Get your “Featured on StopDown” badge →